Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Nextcure, Inc. (NXTC)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Nextcure, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Nextcure, Inc. since 2005.
The reporting company's ticker symbol is NXTC. The reporting company's CIK number is 1661059.
The total value of stock buying since 2005 is $19,875,000.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2019-05-13||Xu Stella (Director)||Buy||125,000||15.00||1,875,000|
|2019-05-13||Orbimed Capital Gp Vi Llc (Director)||Buy||350,000||15.00||5,250,000|
|2019-05-13||Canaan Partners X Llc (10% Owner)||Buy||50,000||15.00||750,000|
|2019-05-13||Khuong Chau Quang (Director)||Buy||350,000||15.00||5,250,000|
|2019-05-13||Shannon Timothy M (Director)||Buy||50,000||15.00||750,000|
Insider trading activities including stock purchases, stock sales, and option exercises of NXTC listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Nextcure, Inc. (symbol NXTC, CIK number 1661059) see the Securities and Exchange Commission (SEC) website.